Bertram J S, Pung A, Churley M, Kappock T J, Wilkins L R, Cooney R V
Molecular Oncology Program, University of Hawaii, Honolulu 96813.
Carcinogenesis. 1991 Apr;12(4):671-8. doi: 10.1093/carcin/12.4.671.
The ability of diverse carotenoid to inhibit methylcholanthrene-induced transformation of 10T1/2 cells has been investigated. When delivered using tetrahydrofuran as a novel solvent, all carotenoids were absorbed by cultured cells. When continuously administered to methylcholanthrene-treated cultures 7 days after removal of the carcinogen, canthaxanthin, beta-carotene, alpha-carotene and lycopene inhibited the production of transformed foci in a dose-dependent manner in the above order of potency. This activity was not associated with drug toxicity or antiproliferative effects. Renierapurpurin and bixin did not inhibit transformation at concentrations less than or equal to 10(-5) M. Lutein was inhibitory at 10(-5) M, but was inactive at lower concentrations. Because of differences in stability in culture medium (alpha-carotene less than beta-carotene less than canthaxanthin less than lycopene less than lutein) and structure, cellular levels of drug differed up to 8-fold after administration of identical concentrations of compounds. Carotenoids with polar groups achieved highest cellular levels, however cellular uptake did not correlate with activity. For example, lutein, the most polar and most stable, reached the highest concentration in cells yet required a concentration of 10(-5) M for activity in the transformation assay, while alpha-carotene, the least stable and least concentrated by cells, was comparably active at 3 X 10(6) M. alpha-Tocopherol, a potent lipid-phase antioxidant, was as active as lycopene in the transformation assay but at a 10-fold higher concentration did not approach the activity of beta-carotene or canthaxanthin. Because the most potent of the carotenoids tested (i.e. beta-carotene, alpha-carotene, canthaxanthin) all have the potential for conversion to retinoids (though this has never been demonstrated in mammals for canthaxanthin), it is suggested that these compounds have two components to their action; one related to their antioxidant properties, the other to their pro-vitamin A activities.
研究了多种类胡萝卜素抑制甲基胆蒽诱导的10T1/2细胞转化的能力。当使用四氢呋喃作为新型溶剂给药时,所有类胡萝卜素均被培养细胞吸收。在去除致癌物7天后,将其连续给予经甲基胆蒽处理的培养物,角黄素、β-胡萝卜素、α-胡萝卜素和番茄红素以上述效力顺序以剂量依赖方式抑制转化灶的产生。该活性与药物毒性或抗增殖作用无关。在浓度小于或等于10(-5)M时,雷尼拉紫红素和胭脂树橙不抑制转化。叶黄素在10(-5)M时具有抑制作用,但在较低浓度时无活性。由于在培养基中的稳定性不同(α-胡萝卜素<β-胡萝卜素<角黄素<番茄红素<叶黄素)以及结构差异,给予相同浓度的化合物后,细胞内药物水平相差高达8倍。具有极性基团的类胡萝卜素在细胞内达到最高水平,然而细胞摄取与活性并不相关。例如,极性最强且最稳定的叶黄素在细胞内达到最高浓度,但在转化试验中发挥活性需要10(-5)M的浓度,而α-胡萝卜素稳定性最差且细胞摄取浓度最低,在3×10(6)M时具有相当的活性。α-生育酚是一种有效的脂相抗氧化剂,在转化试验中与番茄红素活性相当,但浓度高10倍时仍未达到β-胡萝卜素或角黄素的活性。由于所测试的最有效的类胡萝卜素(即β-胡萝卜素、α-胡萝卜素、角黄素)都有转化为视黄醇的潜力(尽管角黄素在哺乳动物中从未被证明有此转化),因此提示这些化合物的作用有两个成分;一个与其抗氧化特性有关,另一个与其维生素A原活性有关。